-
Chronic insomnia in older adults improved more with objective measures when treated with cognitive behavioral therapy rather than nightly medications.
-
The FDA has given an accelerated approval for a new protease inhibitor (PI) for the treatment of HIV infections. Darunavir (TMC114) is approved for patients who have shown resistance to more than one protease inhibitor.
-
The two non-sequential lead II rhythm strips shown in the image were interpreted as showing "sinus tachycardia (top strip) with sudden development of PSVT" (lower strip).
-
Cephalosporins should be considered for penicillin-allergic patients due to low cross-reactivity risk, but these patients do have a small increased risk of subsequent reactions to both sulfonamides and cephalosporins.
-
Black cohosh, when studied in appropriate randomized trials, is no different than placebo treatment in affecting hot flushing.
-
Borrelia persica is the causative agent of tick-borne relapsing fever (TBRF). The Borrelia name will be familiar to clinicians because of Lyme disease, caused by Borrelia burgdorferi.
-
Do long-acting beta agonist inhalers increase the severity of asthma? Yes, according to the results from a large meta-analysis recently published in the Annals of Internal Medicine.
-
Apparently healthy, middle-aged and older subjects with frequent PVCs have a poor prognosis and should be considered to be high-risk subjects who require strict risk factor modification and primary prevention.
-
Barotrauma to the paranasal sinuses may cause sudden and severe headache during airplane travel.
-
The number of previous acute exacerbations of chronic bronchitis (AECBs) and the baseline FEV1 level are potent prognostic factors of the short and long-term outcomes of AECB.
